These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8146828)
21. [Vaccines' adverse events: questions and answers brought by InfoVac]. Cohen R; Siegrist CA Arch Pediatr; 2006 Jun; 13(6):650-2. PubMed ID: 16690277 [No Abstract] [Full Text] [Related]
22. [Pharmacovigilance of antibiotics. Evaluation by the Midi-Pyrénées Pharmacovigilance Center between 1989 and 1992]. Llau ME; Damase-Michel C; Lapeyre-Mestre M; Vie M; Rascol O Therapie; 1994; 49(2):123-7. PubMed ID: 7817335 [TBL] [Abstract][Full Text] [Related]
23. [Regional Centers of Pharmacovigilance: a complementary source of efficiency]. Mazé F; Bégaud B Therapie; 1998; 53(4):397-400. PubMed ID: 9806011 [TBL] [Abstract][Full Text] [Related]
24. [Pharmacovigilance off the beaten track: herbal surveillance or pharmacovigilance of medicinal plants]. Castot A; Djezzar S; Deleau N; Guillot B; Efthymiou ML Therapie; 1997; 52(2):97-103. PubMed ID: 9231502 [TBL] [Abstract][Full Text] [Related]
25. Pharmacovigilance: what to do if you see an adverse reaction and the consequences. Stenver DI Eur J Radiol; 2008 May; 66(2):184-6. PubMed ID: 18372136 [TBL] [Abstract][Full Text] [Related]
26. Spontaneous reporting of adverse drug reactions: who reports and what? Tubert-Bitter P; Haramburu F; Begaud B; Chaslerie A; Abraham E; Hagry C Pharmacoepidemiol Drug Saf; 1998 Sep; 7(5):323-9. PubMed ID: 15073979 [TBL] [Abstract][Full Text] [Related]
28. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database. Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL; Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603 [TBL] [Abstract][Full Text] [Related]
29. Post Launch Monitoring of food products: what can be learned from pharmacovigilance. van Puijenbroek EP; Hepburn PA; Herd TM; van Grootheest AC Regul Toxicol Pharmacol; 2007 Mar; 47(2):213-20. PubMed ID: 17204356 [TBL] [Abstract][Full Text] [Related]
30. European pharmacovigilance: an overview of pharmacovigilance inspections. Koster MC; van den Oetelaar AH Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):711-3. PubMed ID: 16142691 [No Abstract] [Full Text] [Related]
31. European pharmacovigilance legislation: has it led to implementation of pharmacovigilance inspections? Bleumink GS; in't Veld BA; Stricker BH Pharmacoepidemiol Drug Saf; 2001; 10(4):339-40. PubMed ID: 11760496 [No Abstract] [Full Text] [Related]
33. Decision support methods for the detection of adverse events in post-marketing data. Hauben M; Bate A Drug Discov Today; 2009 Apr; 14(7-8):343-57. PubMed ID: 19187799 [TBL] [Abstract][Full Text] [Related]
34. Nurses are increasingly involved in pharmacovigilance in Sweden. Ulfvarson J; Mejyr S; Bergman U Pharmacoepidemiol Drug Saf; 2007 May; 16(5):532-7. PubMed ID: 17072915 [TBL] [Abstract][Full Text] [Related]
35. European commission consultation on pharmacovigilance. Waller P; Beard K; Egberts T; Evans S; Hallas J; Hasford J; Laporte JR; Moore N; Shakir S; Sturkenboom M Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):108-9. PubMed ID: 18058839 [No Abstract] [Full Text] [Related]
36. [Drug information and prescription guidance: role of regional centers of pharmacovigilance]. Blayac JP; Haramburu F; Lerebours S; Vial T Presse Med; 2000 Jan; 29(2):115-8. PubMed ID: 10682043 [TBL] [Abstract][Full Text] [Related]
37. [Pharmacovigilance seen by a selected group of general practitioners and of residents in the Midi-Pyrénées region]. Pouget-Zago P; Lapeyre-Mestre M; Bagheri H; Montastruc JL Therapie; 1995; 50(5):459-62. PubMed ID: 8571286 [TBL] [Abstract][Full Text] [Related]
38. Health authorities and drug utilization studies. Garcia Alonso F; Scott AI; Stika L; Westerholm B WHO Reg Publ Eur Ser; 1993; 45():147-67. PubMed ID: 8442843 [No Abstract] [Full Text] [Related]
39. Development of pharmacovigilance system in Ukraine: first results. Stefanov O; Sharayeva M; Jajtchenja V Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):197-9. PubMed ID: 15072120 [TBL] [Abstract][Full Text] [Related]
40. A model for the future conduct of pharmacovigilance. Waller PC; Evans SJ Pharmacoepidemiol Drug Saf; 2003; 12(1):17-29. PubMed ID: 12616844 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]